PRRT2 and Alzheimer disease: Although the activation of some PKC isoforms, such as PKCα and ε, has been shown to regulate nonamyloidogenic pathways and Aβ degradation, it is unclear whether other PKC isoforms are involved in β-amyloid precursor protein (APP) processing and the pathogenesis of AD.